Invention Grant
- Patent Title: Modulation of tumor immunity
-
Application No.: US15926035Application Date: 2018-03-20
-
Publication No.: US10994008B2Publication Date: 2021-05-04
- Inventor: Gu Danling , Amy M. Beebe
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Yingying Zeng; John C. Todaro
- Main IPC: A61K39/39
- IPC: A61K39/39 ; A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
Methods of treating proliferative disorders are described. In particular, combination treatment with a GITR agonist and a PD-1 antagonist are provided.
Public/Granted literature
- US20180207266A1 MODULATION OF TUMOR IMMUNITY Public/Granted day:2018-07-26
Information query
